Effects of inhaled beclometasone dipropionate/formoterol fumarate/glycopyrronium vs. beclometasone dipropionate/formoterol fumarate and placebo on lung hyperinflation and exercise endurance in chronic obstructive pulmonary disease: a randomised controlled trial
2024; BioMed Central; Volume: 25; Issue: 1 Linguagem: Inglês
10.1186/s12931-024-02993-x
ISSN1465-993X
AutoresHenrik Watz, Anne‐Marie Kirsten, Andrea Ludwig-Sengpiel, Matthias Krüll, Robert Mróz, George Georges, Guido Varoli, Rémi Charretier, Mauro Cortellini, Andrea Vele, Dmitry Galkin,
Tópico(s)Respiratory Support and Mechanisms
ResumoThe single-inhaler triple combination of beclometasone dipropionate, formoterol fumarate, and glycopyrronium (BDP/FF/G) is available for maintenance therapy of chronic obstructive pulmonary disease (COPD). Cardinal features of COPD are lung hyperinflation and reduced exercise capacity. TRIFORCE aimed to evaluate the effect of BDP/FF/G on lung hyperinflation and exercise capacity in patients with COPD.
Referência(s)